Cell applications公司 Cell applications代理 Cell applications**代理 Cell applications中国代理
Cell applications公司是全球原代细胞培养产品的供应商，提供一系列原代细胞、优化的培养基、细胞培养试剂和抗体等
细胞BAsed实验在许多今天的医疗突破中发挥了重要作用。药物筛选，毒性试验，癌症研究，病毒学，细胞培养sed制造，模型系统和基因治疗取决于优越的细胞培养系统，从生理环境中去除细胞并且在高度公司中建立了不断增长的细胞群体人工环境。
用于这些实验的细胞类型是至关重要的。永生化的细胞系相对容易生长和使用，但是这些细胞在培养中被广泛修饰和传代并不罕见，因为这些细胞丧失生理特性。比较研究显示，例如，内皮细胞系缺乏主要内皮细胞的独特表型（Unger，2002）。另外，使用Cell Applications，Inc.原始细胞，移民差异是演示在初级和永生化上皮细胞之间（Lee，2005），以及初级和永生化角化细胞之间（Akaza，2011）。使用细胞系的实验室投入时间和资源可能无关紧要的结果造成风险。
原代细胞直接来源于活体组织，更可能代表生理行为。然而，由于初级细胞的分离，纯化和*佳生长的确定尽管潜在的细胞系使用陷阱，科学家们本身仍然可以使用细胞系，但其本身可能是昂贵的努力。
1994年，Cell Applications公司认识到对原代细胞的需求，并开始激发从细胞系到原代细胞的这一范式转变。我们拥有多年的经验，处理了众多臭名昭着的原始细胞类型，我们有ho确定了原代细胞的分离，纯化，亚文化和生长工艺。我们公司建立在高纯度，严格品质的公司的基础上包括和特征的原代细胞，包括超过100种不同的人和动物原代细胞类型，以及细胞生长培养基和细胞培养试剂，生物标志物和信号传导抗体。这些包括一个公司不断增长的细胞培养工具箱。
我们的客户包括国际**的大学和研究机构，以及**的生物科技，制药和公司的精英们nsumer产品公司。Cell Applications，Inc.提供的细胞用于产生诱导性多能干细胞（iPS），其中有数百其他高影响研究发现，山梨神奈山医院获得2012年诺贝尔奖（Takanashi，2007）。作为原始细胞和细胞培养产品的优选来源，我们欢迎有机会促进您的细胞培养项目和发现。
Cell-based experiments have played an essential role in many of today’s medical breakthroughs. Drug screening, toxicity tests, cancer research, virology, cell-based manufacturing, model systems, and gene therapy depend on a superior cell culture system, the removal of cells from a physiological environment and the establishment of a growing cell population in a highly controlled artificial environment.
The cell type used for these experiments is critical. Immortalized cell lines are relatively easy to grow and use, but it is not uncommon for these cells to lose physiological properties, as they have been modified and passaged extensively in culture. Comparative studies show, for example, that endothelial cell lines lack the distinctive phenotypes of primary endothelial cells (Unger, 2002). Additionally, using Cell Applications, Inc. primary cells, important differences were demonstrated between primary and immortalized epithelial cells (Lee, 2005), as well as between primary and immortalized keratinocytes (Akaza, 2011). A laboratory that uses cell lines takes on considerable risk by investing time and resources on a potentially irrelevant result.
Primary cells are derived directly from living tissue, and are more likely to represent physiological behavior. However, because primary cell isolation, purification, and determination of optimal growth conditions can be a costly endeavor in and of itself, scientists still use cell lines despite the potential pitfalls of cell line usage.
In 1994, Cell Applications, Inc. recognized the demand for primary cells and set out to galvanize this paradigm shift from cell lines to primary cells. With years of experience handling numerous notoriously finicky primary cell types, we have honed the craft of isolation, purification, subculture, and growth of primary cells. Our company is built on high purity, strictly quality controlled and characterized primary cells, including over 100 different human and animal primary cell types, as well as cell growth media and cell culture reagents, biomarkers and signaling antibodies. These comprise a continuously growing cell culture toolbox.
Our customers include international luminaries at leading universities and research institutes, as well as cutting edge biotech, pharmaceutical, and consumer product companies. Cells provided by Cell Applications, Inc. were used to create induced Pluripotent Stem cells (iPS), the discovery for which Dr. Shinya Yamanaka was awarded the Nobel Prize in 2012 (Takanashi, 2007), among hundreds of other high impact studies. As your number one source for primary cells & cell culture products, we welcome the opportunity to facilitate your cell culture projects and discoveries.
